Removing Lab Players From the Chessboard
IN 1997-98, CEO Ken Freeman of Quest Diagnostics Incorporated made a keen insight about the commercial lab marketplace. At that time the three blood brothersāLaboratory Corporation of America, Quest Diagnostics, and SmithKline Beecham Clinical Laboratories (SBCL)ādominated the national market for physiciansā office testing. Freemanās observation would be prophetic. He noted that, in any industry dominated …
Removing Lab Players From the Chessboard Read More »